Back to Authors

Xu, Kevin

A5079400364 | I4210101297

Mayo Clinic

Jazz Pharmaceuticals (United States)

Citations 1

Design of a Phase 2 Study of Suvecaltamide in Moderate-to-severe Parkinson’s Disease Tremor (P9-3.009)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206381